Effects of long-term lamivudine therapy in renal-transplant patients.

[1]  M. Wulfsohn,et al.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. , 2003, The New England journal of medicine.

[2]  M. Wulfsohn,et al.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. , 2003, The New England journal of medicine.

[3]  O. Musa.  CONTROL OF HEPATITIS B INFECTION , 2003 .

[4]  T. Chan,et al.  Preemptive lamivudine therapy based on HBV DNA level in HBsAg‐positive kidney allograft recipients , 2002, Hepatology.

[5]  C. Mandl,et al.  Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. , 2000, The Journal of infectious diseases.

[6]  Nicholson,et al.  Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L‐FMAU, DAPD, penciclovir and lobucavir , 2000, Journal of viral hepatitis.

[7]  D. Pillay,et al.  High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. , 1999, Journal of hepatology.

[8]  P Coriat,et al.  Impact of hepatitis B and C virus on kidney transplantation outcome , 1999, Hepatology.

[9]  D. Pillay,et al.  Analysis of Hepatitis B Virus Quasispecies Changes during Emergence and Reversion of Lamivudine Resistance in Liver Transplantation , 1999, Antiviral therapy.

[10]  C. Gibbs,et al.  Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro , 1998, Hepatology.

[11]  W. Yang,et al.  Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. , 1998, Transplantation.

[12]  N. Leung,et al.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 1998, The New England journal of medicine.

[13]  A. Bartholomeusz,et al.  Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease , 1998 .

[14]  L. Rostaing,et al.  Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. , 1997, Transplantation.

[15]  Chiu-Ching Huang,et al.  Hepatitis in patients with end‐stage renal disease , 1997, Journal of gastroenterology and hepatology.

[16]  P. Chossegros,et al.  Treatment of hepatitis B virus replication by ganciclovir in kidney transplant patients. , 1997, Transplantation proceedings.

[17]  A. Burroughs,et al.  Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis , 1996, The Lancet.

[18]  H. Schaller,et al.  Hepatitis B virus replication‐an update , 1996, Journal of viral hepatitis.

[19]  F. Carnot,et al.  The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. , 1996, Transplantation.

[20]  M. Manns,et al.  Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  L. Rostaing,et al.  Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. , 1996, Nephron.

[22]  E. Schiff,et al.  A preliminary trial of lamivudine for chronic hepatitis B infection. , 1995, The New England journal of medicine.

[23]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[24]  A. Couroucé,et al.  Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. , 1994, Virology.

[25]  A. Detsky,et al.  Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1993, Annals of Internal Medicine.

[26]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[27]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[28]  M. Lavenhar,et al.  Control of hepatitis B infection. The role of surveillance and an isolation hemodialysis center. , 1981, JAMA.